Rebooting atrial fibrillation ablation in the COVID-19 pandemic.
Atrial fibrillation
COVID
Catheter ablation
Procedural outcomes
Radiofrequency ablation
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
03
12
2020
accepted:
24
01
2021
pubmed:
6
2
2021
medline:
15
1
2022
entrez:
5
2
2021
Statut:
ppublish
Résumé
Catheter ablation procedures for atrial fibrillation (AF) were significantly curtailed during the peak of coronavirus disease 2019 (COVID-19) pandemic to conserve healthcare resources and limit exposure. There is little data regarding peri-procedural outcomes of medical procedures during the COVID-19 pandemic. We enacted protocols to safely reboot AF ablation while limiting healthcare resource utilization. We aimed to evaluate acute and subacute outcomes of protocols instituted for reboot of AF ablation during the COVID-19 pandemic. Perioperative healthcare utilization and acute procedural outcomes were analyzed for consecutive patients undergoing AF ablation under COVID-19 protocols (2020 cohort; n=111) and compared to those of patients who underwent AF ablation during the same time period in 2019 (2019 cohort; n=200). Newly implemented practices included preoperative COVID-19 testing, selective transesophageal echocardiography (TEE), utilization of venous closure, and same-day discharge when clinically appropriate. Pre-ablation COVID-19 testing was positive in 1 of 111 patients. There were 0 cases ablation-related COVID-19 transmission and 0 major complications in either cohort. Pre-procedure TEE was performed in significantly fewer 2020 cohort patients compared to the 2019 cohort patients (68.4% vs. 97.5%, p <0.001, respectively) despite greater prevalence of persistent arrhythmia in the 2020 cohort. Same-day discharge was achieved in 68% of patients in the 2020 cohort, compared to 0% of patients in the 2019 cohort. Our findings demonstrate the feasibility of safe resumption of complex electrophysiology procedures during the COVID-19 pandemic, reducing healthcare utilization and maintaining quality of care. Protocols instituted may be generalizable to other types of procedures and settings.
Identifiants
pubmed: 33543350
doi: 10.1007/s10840-021-00952-w
pii: 10.1007/s10840-021-00952-w
pmc: PMC7861463
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-101Informations de copyright
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.
Références
Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, et al. Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: endorsed by the American College of Cardiology. Heart Rhythm. 2020. https://doi.org/10.1016/j.hrthm.2020.06.012 .
Diaz A, Sarac BA, Schoenbrunner AR, Janis JE, Pawlik TM. Elective surgery in the time of COVID-19. Am J Surg. 2020;219(6):900–2. https://doi.org/10.1016/j.amjsurg.2020.04.014 .
doi: 10.1016/j.amjsurg.2020.04.014
pubmed: 32312477
pmcid: 7161516
Rubin GA, Wan EY, Saluja D, Thomas G, Slotwiner DJ, Goldbarg S, et al. Restructuring electrophysiology during the COVID-19 pandemic: a practical guide from a New York City Hospital Network. Crit Pathw Cardiol. 2020;19(3):105–11. https://doi.org/10.1097/HPC.0000000000000225 .
doi: 10.1097/HPC.0000000000000225
pubmed: 32324622
Czeisler MÉ, Marynak K, Clarke KEN, Sala Z, Shakya I, Thierry JM, et al. Delay or avoidance of medical care because of COVID-19–related concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1250–7. https://doi.org/10.15585/mmwr.mm6936a4externalicon .
doi: 10.15585/mmwr.mm6936a4externalicon
pubmed: 32915166
pmcid: 7499838
Tripathi B, Atti V, Kumar V, Naraparaju V, Sharma P, Arora S, et al. Outcomes and resource utilization associated with readmissions after atrial fibrillation hospitalizations. J Am Heart Assoc. 2019;8(19):e013026. https://doi.org/10.1161/JAHA.119.013026 .
doi: 10.1161/JAHA.119.013026
pubmed: 31533511
pmcid: 6806041
Haegeli LM, Duru F, Lockwood EE, Luscher TF, Sterns LD, Novak PG, et al. Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation. Postgrad Med J. 2010;86(1017):395–8. https://doi.org/10.1136/pgmj.2009.092510 .
doi: 10.1136/pgmj.2009.092510
pubmed: 20634248
Ignacio M, Jarma JJ, Nicolas V, Gustavo D, Leandro T, Milagros C, et al. Current safety of pulmonary vein isolation in paroxysmal atrial fibrillation: first experience of same day discharge. J Atr Fibrillation. 2019;11(4). https://doi.org/10.4022/jafib.2077 .
Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio DB, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: the AMBULATE Trial. JACC Clin Electrophysiol. 2020;6(1):111–24. https://doi.org/10.1016/j.jacep.2019.08.013 .
doi: 10.1016/j.jacep.2019.08.013
pubmed: 31971899
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606. https://doi.org/10.1093/europace/eus027 .
doi: 10.1093/europace/eus027
pubmed: 22389422
COVID-19: Data. NYC Health. 2020.